Blair Lonsberry, OD: AbbVie/Allergan: Advisory Committee/Board Member (); Apellis: Speaker's Bureau (honoraria or other compensation) (); Sun Pharma: Speaker's Bureau (honoraria or other compensation) (); Tarsus: Advisory Committee/Board Member (); Thea Pharma: Advisory Committee/Board Member ()
Diabetic retinopathy is a leading cause of blindness and a well-known complication of diabetes. Diabetes has other influences and affects on the ocular system, and this presentation will utilize the latest in interactive technology to review the numerous ocular complications associated with diabetes. Current diabetes diagnosis, treatment and management will also be discussed.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Become familiar with the different classifications and characteristics within diabetes
Understand the effects of diabetes on the orbital structures of the eye
Identify the different classifications of diabetic retinopathy including signs and symptoms
Learn the diagnostic criteria for DME and treatment
